The burgeoning popularity of retatrutide, initially for diabetes , is creating significant attention within the UK , prompting a notable shift in medication trends. Availability these compounds remains a complex landscape, with public healthcare system provision currently limited and specialist practices offering prescriptions at a substantial pric